A quasi-monoclonal anti-HBs response can lead to immune escape of ‘wild-type’ hepatitis B virus
- 1 June 2005
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 86 (6) , 1687-1693
Abstract
Hepatitis B virus (HBV) infections can be prevented or controlled by the host humoral immune response (anti-HBs) directed against the major surface antigen (HBsAg), elicited either naturally or by vaccination. A chronic HBV carrier was found to have high levels of both virus and anti-HBs. Full-length HBV genomes were amplified from the patient's serum, sequenced and cloned. The genome was ‘wild-type’ HBV of genotype C and serotypeadr. The sequence has remained stable, with no signs of emergence of an immune-escape mutant population. To study what was recognized by the patient's serum, viral particles were35S-labelled and then immunoprecipitated by using the patient's serum or control sera. The patient's serum immunoprecipitated theadrHBsAg encoded by his HBV genome poorly, but efficiently recognized HBsAg of serotypeayw. When his HBV genome was modified by a point mutation to express HBsAg of serotypeayr, the patient's serum could recognize the antigen, as well as the control anti-HBs-positive serum. The patient appeared to have made a quasi-monoclonal humoral response to theyepitope. By switching to thedepitope, which requires only a point mutation, the virus could replicate, despite the high levels of anti-HBs. This study underlines the subtleties of virus–host interactions. Implications for HBV vaccination are discussed.Keywords
This publication has 34 references indexed in Scilit:
- Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg SubtypesIntervirology, 2004
- Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patientHepatology, 2002
- Phylogenetic Origin of Hepatitis B Virus Strains with Precore C-1858 VariantJournal of Clinical Microbiology, 2001
- Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assaysHepatology, 2000
- Prevalence and Significance of Naturally Occurring Mutations in the Surface and Polymerase Genes of Hepatitis B VirusThe Journal of Infectious Diseases, 1999
- Hepatitis B vaccination in infancy in The Gambia: protectionVaccine, 1999
- What Level of Hepatitis B Antibody Is Protective?The Journal of Infectious Diseases, 1999
- Identification of Hepatitis B Surface Antigen Variants with Alterations outside the “a” Determinant in Immunized Singapore InfantsThe Journal of Infectious Diseases, 1999
- Prediction of Transmembrane Segments in Proteins Utilising Multiple Sequence AlignmentsJournal of Molecular Biology, 1994
- Molecular basis of hepatitis B virus serotype variations within the four major subtypesJournal of General Virology, 1992